Mumbai, 16 December (Udaipur Kiran) — Shares of Biocon moved higher on Monday after the company announced the launch of its GLP-1 peptide, Liraglutide, in the Netherlands for diabetes and obesity management. The stock was trading at Rs. 391.30, up 1.20% from its previous close of Rs. 386.65. It opened at Rs. 387.45 and touched […]